GSN KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon6 and 20 bp deletion in exon6.
Images
Key facts
- Cell type
- HeLa
- Species or organism
- Human
- Tissue
- Cervix
- Knockout validation
- Sanger Sequencing, Western blot
- Mutation description
- Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon6 and 20 bp deletion in exon6.
Alternative names
ADF, AGEL, Actin-depolymerizing factor, Brevin, DKFZp313L0718, GELS_HUMAN, Gelsolin, Gsn
What's included?
Recommended products
GSN KO cell lysate available now. KO validated by Western blot. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon6 and 20 bp deletion in exon6.
Key facts
- Cell type
- HeLa
- Species or organism
- Human
- Tissue
- Cervix
- Knockout validation
- Sanger Sequencing, Western blot
- Mutation description
- Knockout achieved by using CRISPR/Cas9, 1 bp deletion in exon6 and 20 bp deletion in exon6.
- Disease
- Adenocarcinoma
- Concentration
Properties
- Gene name
- GSN
- Gene editing type
- Knockout
- Gene editing method
- CRISPR technology
- Knockout validation
- Sanger Sequencing, Western blot
Quality control
- STR analysis
- CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX
Cell culture
- Biosafety level
- EU: 2 US: 2
- Adherent/suspension
- Adherent
- Gender
- Female
Storage
- Shipped at conditions
- Ambient - Can Ship with Ice
- Appropriate short-term storage conditions
- -20°C
- Appropriate long-term storage conditions
- -20°C
Notes
Knockout cell lysate achieved by CRISPR/Cas9.
Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.
Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.
User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.
This product is subject to limited use licenses from The Broad Institute and ERS Genomics Limited, and is developed with patented technology. For full details of the limited use licenses and relevant patents please refer to our limited use license and patent pages.
Supplementary info
- This supplementary information is collated from multiple sources and compiled automatically.
- Activity summary
Gelsolin is a multifunctional actin-binding protein that exists in two main isoforms: cytoplasmic and plasma. It has a molecular mass of approximately 82 kDa. Gelsolin is expressed in a wide range of tissues including muscle epithelial and nerve cells. The protein's main mechanical function involves severing actin filaments which helps to regulate actin polymerization and depolymerization. Researchers sometimes refer to gelsolin as 'GSN'. The presence of the protein helps maintain the dynamic organization of the cytoskeleton by interacting with actin filaments.
- Biological function summary
This protein acts in cell movement apoptosis and signal transduction. Gelsolin contributes to the remodeling of the actin cytoskeleton by promoting the disassembly of actin filaments allowing cells to change shape and move. Although it operates independently gelsolin’s activity can be influenced by calcium ions and phosphoinositides leading to its participation in various cellular activities. Gelsolin plays a role in platelet activation and may regulate cellular responses through association with the cytoskeletal complex.
- Pathways
Gelsolin participates in the regulation of the actin cytoskeleton and apoptotic pathways. Within these pathways gelsolin interacts with proteins like cofilin to modulate actin filament dynamics. In apoptotic pathways it collaborates by altering the cytoskeletal architecture impacting cell death mechanisms. Gelsolin modifications in these pathways have implications for cellular processes like cell migration and apoptosis bringing it into relation with proteins such as caspases.
- Associated diseases and disorders
Gelsolin is linked to conditions such as gelsolin amyloidosis and cancer metastasis. Gelsolin amyloidosis results from mutations in the gelsolin gene which lead to the formation of amyloid fibrils causing dysfunction in nerves eyes and skin. In cancer altered gelsolin expression can influence tumor progression and metastasis through its role in cell motility. Related proteins such as actin and caspases could also play a part in these conditions either through direct interaction or through pathways in which gelsolin functions.
Product promise
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
5 product images
Western blot - Human GSN (Gelsolin) knockout HeLa cell lysate (ab257204)
Lane 1: Wild-type HeLa cell lysate (20 ug)
Lane 2: Human GSN knockout HeLa cell lysate (20 ug)Anti-Gelsolin antibody [EPR1942] ab109014 was shown to react with GSN in wild-type HeLa cells in Western blot with loss of signal observed in GSN knockout cell line Human GSN (Gelsolin) knockout HeLa cell line ab265201 (GSN knockout cell lysate ab257204). Wild-type HeLa and GSN knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with Anti-Gelsolin antibody [EPR1942] ab109014 overnight at 4 °C at a 1/20000 dilution. Blots were incubated with goat anti-rabbit HRP secondary antibodies at 1/5000 before imaging. These data were provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes: Western blot - Anti-Gelsolin antibody [EPR1942] (Anti-Gelsolin antibody [EPR1942] ab109014) at 1/20000 dilution
Lane 1: Wild-type HeLa cell lysate at 20 µg
Lane 2: GSN knockout HeLa cell lysate at 20 µg
Lane 2: Western blot - Human GSN (Gelsolin) knockout HeLa cell line (Human GSN (Gelsolin) knockout HeLa cell line ab265201)
Performed under reducing conditions.
Predicted band size: 86 kDa
Western blot - Human GSN (Gelsolin) knockout HeLa cell lysate (ab257204)
Lane 1: Wild-type HeLa cell lysate (20 ug)
Lane 2: Human GSN knockout HeLa cell lysate (20 ug)Anti-Gelsolin antibody [GS-2C4] ab11081 was shown to react with GSN in wild-type HeLa cells in Western blot with loss of signal observed in GSN knockout cell line Human GSN (Gelsolin) knockout HeLa cell line ab265201 (GSN knockout cell lysate ab257204). Wild-type HeLa and GSN knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with Anti-Gelsolin antibody [GS-2C4] ab11081 overnight at 4 °C at a 1/200 dilution. Blots were incubated with goat anti-mouse HRP secondary antibodies at 1/5000 before imaging. This data was kindly provided by the YCharOS Inc., an open science company with the mission of characterizing every commercially available antibody reagent. Abcam are working with YCharOS to support their mission of antibody characterisation using knockout cell lines.
All lanes: Western blot - Anti-Gelsolin antibody (Anti-Gelsolin antibody ab74420) at 1/20000 dilution
Lane 1: Wild-type HeLa cell lysate at 20 µg
Lane 2: GSN knockout HeLa cell lysate at 20 µg
Lane 2: Western blot - Human GSN (Gelsolin) knockout HeLa cell line (Human GSN (Gelsolin) knockout HeLa cell line ab265201)
Performed under reducing conditions.
Predicted band size: 86 kDa
Western blot - Human GSN (Gelsolin) knockout HeLa cell lysate (ab257204)
Lane 1: Wild-type HeLa cell lysate (20 ug)
Lane 2: Human GSN knockout HeLa cell lysate (20 ug)Anti-Gelsolin antibody ab74420 was shown to react with GSN in wild-type HeLa cells in Western blot with loss of signal observed in GSN knockout cell line Human GSN (Gelsolin) knockout HeLa cell line ab265201 (GSN knockout cell lysate ab257204). Wild-type HeLa and GSN knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with Anti-Gelsolin antibody ab74420 overnight at 4 °C at a 1/20000 dilution. Blots were incubated with goat anti-rabbit HRP secondary antibodies at 1/5000 before imaging. This data was kindly provided by the YCharOS Inc., an open science company with the mission of characterizing every commercially available antibody reagent. Abcam are working with YCharOS to support their mission of antibody characterisation using knockout cell lines.
All lanes: Western blot - Anti-Gelsolin antibody [GS-2C4] (Anti-Gelsolin antibody [GS-2C4] ab11081) at 1/200 dilution
Lane 1: Wild-type HeLa cell lysate at 20 µg
Lane 2: GSN knockout HeLa cell lysate at 20 µg
Lane 2: Western blot - Human GSN (Gelsolin) knockout HeLa cell line (Human GSN (Gelsolin) knockout HeLa cell line ab265201)
Performed under reducing conditions.
Predicted band size: 86 kDa
Sanger Sequencing - Human GSN (Gelsolin) knockout HeLa cell lysate (ab257204)
Allele-2: 1 bp deletion in exon6
Sanger Sequencing - Human GSN (Gelsolin) knockout HeLa cell lysate (ab257204)
Allele-1: 20 bp deletion in exon6
Downloads
Product protocols
- Visit the general protocols
- Visit troubleshooting
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com